U.S., Aug. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07137351) titled 'The Biosensor Using the Target Urine VOCs for Detecting DKD Diabetic Kidney Disease' on June 07, 2024.
Brief Summary: Volatile organic compounds (VOCs) are easily evaporated substances produced by pathophysiologic metabolism and have been utilized in research as potential new biomarkers for differentiating various diseases, acting as the odor imprints of each disease.
Researchers used metal oxide semiconductors to examine the properties of VOCs produced by diabetic kidney disease patients. Also, the VOCs of those with diabetic kidney disease were then compared with those of healthy individuals and patients with nephrotic syndrome....